[1]
2026. Efficacy and Safety of Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Trials by Race. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s769. DOI:https://doi.org/10.25251/e6gpah49.